Lucigen Corp. has raised almost $2 million from outside investors, according to the U.S. Securities and Exchange Commission. The money will help the Madison biotech firm further develop diagnostic tests for Ebola and other diseases.
Lucigen raises $2M in investments
Get Our Email Newsletter
The companies, people and issues shaping business in Madison and the Capital Region.
